LifeStance Health (LFST) Cash & Current Investments (2021 - 2025)
Historic Cash & Current Investments for LifeStance Health (LFST) over the last 5 years, with Q3 2025 value amounting to $203.9 million.
- LifeStance Health's Cash & Current Investments rose 9670.17% to $203.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $203.9 million, marking a year-over-year increase of 9670.17%. This contributed to the annual value of $155.8 million for FY2024, which is 9062.2% up from last year.
- According to the latest figures from Q3 2025, LifeStance Health's Cash & Current Investments is $203.9 million, which was up 9670.17% from $189.4 million recorded in Q2 2025.
- LifeStance Health's 5-year Cash & Current Investments high stood at $276.2 million for Q2 2021, and its period low was $48.5 million during Q3 2023.
- In the last 5 years, LifeStance Health's Cash & Current Investments had a median value of $119.7 million in 2022 and averaged $132.5 million.
- In the last 5 years, LifeStance Health's Cash & Current Investments crashed by 6499.26% in 2022 and then skyrocketed by 15332.25% in 2025.
- LifeStance Health's Cash & Current Investments (Quarter) stood at $148.0 million in 2021, then decreased by 23.63% to $113.0 million in 2022, then fell by 27.68% to $81.8 million in 2023, then skyrocketed by 90.62% to $155.8 million in 2024, then soared by 30.84% to $203.9 million in 2025.
- Its Cash & Current Investments was $203.9 million in Q3 2025, compared to $189.4 million in Q2 2025 and $135.2 million in Q1 2025.